News and views for the UB community
Pharmacy professor Edward Bednarczyk discusses an online training program for prescribers and other efforts.
The team found several therapeutic vulnerabilities of drug resistance that could be targeted to improve outcomes.
The council provides a national forum where medical school deans address critical issues facing academic medicine.
Nicholas Cucciniello will use the award to do thesis-related work at Los Alamos National Laboratory.
UB CIGBS scholar Waheed Adedeji will investigate the influence of antidepressants on HIV medication among patients in Nigeria.
The UB-developed scoring system is twice as accurate at predicting antibody resistance among U.S. children with the rare disease.
The SUNY Distinguished Professor has been named the 2022 recipient of the Retina Research Foundation’s Paul Kayser International Award in Retina Research.
A paper published recently by UB mathematicians suggests that “hypergraphs” better explain how neuronal networks communicate.
The results of a UB clinical trial on the drug semaglutide turned out to be better than anything the participants — or researchers — expected.
A UB-led study found that extending the pre-quit duration of a leading smoking cessation medication doesn’t help smokers quit.
Channavix Therapeutics and Peregrine BioVentures are developing patent families related to long-lasting, non-addictive pain therapeutics.